Literature DB >> 33143557

Papillary Thyroid Carcinoma in Ukraine After Chernobyl and in Japan After Fukushima: Different Histopathological Scenarios.

Tetiana I Bogdanova1,2,3, Vladimir A Saenko1, Yuko Hashimoto4, Mitsuyoshi Hirokawa5, Liudmyla Yu Zurnadzhy2, Toshitetsu Hayashi5, Masahiro Ito6, Manabu Iwadate3, Norisato Mitsutake7, Tatiana I Rogounovitch7, Atsuhiko Sakamoto8, Hiroshi Naganuma9, Akira Miyauchi10, Mykola D Tronko11, Geraldine Thomas12, Shunichi Yamashita1,7,13, Shinichi Suzuki3.   

Abstract

Background: A significant increase in the incidence of papillary thyroid carcinoma (PTC) in subjects exposed to radiation at a young age is a well-documented health consequence of the Chernobyl accident. The ongoing Thyroid Ultrasound Examination (TUE) program in children and adolescents of Fukushima Prefecture in Japan also indicated a high prevalence of PTC although its attribution to radiation exposure is a subject of debate. The objective of this study was to perform histopathological analysis of tumor architecture and invasive properties in (i) radiogenic post-Chernobyl and sporadic PTCs from Ukraine, and (ii) PTCs in patients from Fukushima and other Prefectures of Japan of comparable age groups.
Methods: The Ukrainian radiogenic PTCs included 245 PTCs from patients who resided in three highly 131I-contaminated regions and 165 sporadic PTCs diagnosed in residents of the same regions who were born after the accident and therefore not exposed to radioiodine. The Japanese series included 115 PTCs detected during the preliminary and the first full-scale surveys of the TUE in Fukushima and 223 PTCs from patients resident in other Prefectures. All of the subjects were included in the main statistical analysis. Three additional analyses were performed limiting the subjects to children, adolescents, and adults.
Results: Ukrainian radiogenic PTC was characterized by the higher frequency of tumors with a dominant solid-trabecular growth pattern and higher invasiveness, more frequent extrathyroidal extension, lymphatic/vascular invasion, regional and distant metastases when compared with sporadic Ukrainian PTC. The integrative "invasiveness score," based on five cancer characteristics, was also higher in the radiogenic group. The differences were most pronounced in children. In contrast, no significant differences in tumor morphology or invasiveness were observed between the two Japanese groups or the three age subgroups. The only statistically significant findings were the higher proportion of male patients, smaller mean tumor size, and higher frequency of T1b tumors in the Fukushima group. Conclusions: The difference in morphological features that indicate biological behavior of PTC between the radiation-related and sporadic groups from Ukraine, together with the lack of such in the two groups from Japan, strongly suggest a nonradiogenic etiology of PTC from Fukushima and other Prefectures.

Entities:  

Keywords:  Chernobyl; Fukushima; age-matched groups; papillary thyroid carcinoma; pathology; thyroid cancer

Mesh:

Year:  2020        PMID: 33143557     DOI: 10.1089/thy.2020.0308

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  Clinicopathological Implications of the BRAF V600E Mutation in Papillary Thyroid Carcinoma of Ukrainian Patients Exposed to the Chernobyl Radiation in Childhood: A Study for 30 Years After the Accident.

Authors:  Liudmyla Zurnadzhy; Tetiana Bogdanova; Tatiana I Rogounovitch; Masahiro Ito; Mykola Tronko; Shunichi Yamashita; Norisato Mitsutake; Michael Bolgov; Serhii Chernyshov; Sergii Masiuk; Vladimir A Saenko
Journal:  Front Med (Lausanne)       Date:  2022-04-26

2.  Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident.

Authors:  Lindsay M Morton; Danielle M Karyadi; Chip Stewart; Tetiana I Bogdanova; Eric T Dawson; Mia K Steinberg; Jieqiong Dai; Stephen W Hartley; Sara J Schonfeld; Joshua N Sampson; Yosef E Maruvka; Vidushi Kapoor; Dale A Ramsden; Juan Carvajal-Garcia; Charles M Perou; Joel S Parker; Marko Krznaric; Meredith Yeager; Joseph F Boland; Amy Hutchinson; Belynda D Hicks; Casey L Dagnall; Julie M Gastier-Foster; Jay Bowen; Olivia Lee; Mitchell J Machiela; Elizabeth K Cahoon; Alina V Brenner; Kiyohiko Mabuchi; Vladimir Drozdovitch; Sergii Masiuk; Mykola Chepurny; Liudmyla Yu Zurnadzhy; Maureen Hatch; Amy Berrington de Gonzalez; Gerry A Thomas; Mykola D Tronko; Gad Getz; Stephen J Chanock
Journal:  Science       Date:  2021-04-22       Impact factor: 63.714

3.  The BRAFV600E Mutation Is Not a Risk Factor for More Aggressive Tumor Behavior in Radiogenic and Sporadic Papillary Thyroid Carcinoma at a Young Age.

Authors:  Liudmyla Zurnadzhy; Tetiana Bogdanova; Tatiana I Rogounovitch; Masahiro Ito; Mykola Tronko; Shunichi Yamashita; Norisato Mitsutake; Serhii Chernyshov; Sergii Masiuk; Vladimir A Saenko
Journal:  Cancers (Basel)       Date:  2021-11-30       Impact factor: 6.639

4.  Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm.

Authors:  Kristen Romanelli; Justin Wells; Aneeta Patel; Maria Mendonca Torres; John Costello; Kirk Jensen; Vasyl Vasko
Journal:  Ther Adv Endocrinol Metab       Date:  2021-11-24       Impact factor: 3.565

5.  The high degree of similarity in histopathological and clinical characteristics between radiogenic and sporadic papillary thyroid microcarcinomas in young patients.

Authors:  Tetiana Bogdanova; Serhii Chernyshov; Liudmyla Zurnadzhy; Tatiana I Rogounovitch; Norisato Mitsutake; Mykola Tronko; Masahiro Ito; Michael Bolgov; Sergii Masiuk; Shunichi Yamashita; Vladimir A Saenko
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-19       Impact factor: 6.055

6.  Updated Incidence of Thyroid Cancer in the North East Region of Romania after 35 Years of Chernobyl Fallout. Is There a Link between?

Authors:  Laura Teodoriu; Maria Christina Ungureanu; Letitia Leustean; Cristina Preda; Delia Ciobanu; Irena Grierosu; Mioara Matei; Roxana Iacob; Cipriana Stefanescu
Journal:  Diagnostics (Basel)       Date:  2021-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.